Rose P M, Krystek S R, Patel P S, Liu E C, Lynch J S, Lach D A, Fisher S M, Webb M L
Department of Microbial Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543.
FEBS Lett. 1995 Mar 20;361(2-3):243-9. doi: 10.1016/0014-5793(95)00164-5.
The endothelin receptors, ETA and ETB, are G protein-coupled receptors (GPCR) that show distinctively different binding profiles for the endothelin peptides and other ligands. We recently reported that Tyr129 in the second transmembrane region (TM2) of the ETA receptor was critical for subtype-specific ligand binding [Krystek, S.R. et al. (1994) J. Biol. Chem. 269, 12383-12386]. Receptor models indicated that aspartic acids located one helical turn above (Asp133) and below (Asp126) Tyr129 in ETA had their side chains directed toward the putative binding cavity. Similarly in ETB, Asp147 and Asp154 are located one turn below and above His150, the residue that corresponds to Tyr129. Asp126 in ETA and Asp147 in ETB correspond to the highly conserved aspartate present in TM2 of many GPCR that has frequently been shown to be crucial for agonist efficacy. Mutagenesis of Asp126 of the human ETA receptor to alanine resulted in an unaltered affinity for ET-1, a 160-fold increase in ET-3 affinity and a decrease in affinity for the ETA selective naphthalenesulfonamide, BMS-182874. ET-1 activation of phospholipase C was abolished. In addition, despite the gain in binding affinity, ET-3 failed to activate phospholipase C, suggesting that Asp126 is required for signal transduction. Mutagenesis of Asp133 to alanine indicated that it was critical only for the binding of BMS-182874. In the ETB receptor, mutation of His150 to alanine or tyrosine indicated that it plays a minor role in ETB subtype-selective ligand binding; mutation of the aspartates in TM2 of ETB did not alter ligand binding. As in the Asp126 Ala ETA variant, ET-1 and ET-3 failed to increase intracellular levels of inositol phosphates in the Asp147Ala ETB mutant. Taken together, these data support the hypothesis that Asp126 and Asp133 flanking Tyr129 in TM2 of the ETA receptor play a role in defining ETA subtype-selective ligand binding but Asp147 and Asp154 that flank the His150 in TM2 of the ETB receptor do not. Furthermore, these data indicate that Asp126 in ETA and Asp147 in ETB are important for transmembrane signaling via phospholipase C.
内皮素受体ETA和ETB是G蛋白偶联受体(GPCR),它们对内皮素肽和其他配体表现出明显不同的结合特征。我们最近报道,ETA受体第二个跨膜区(TM2)中的Tyr129对于亚型特异性配体结合至关重要[Krystek, S.R.等人(1994年)《生物化学杂志》269, 12383 - 12386]。受体模型表明,ETA中位于Tyr129上方一个螺旋圈(Asp133)和下方(Asp126)的天冬氨酸侧链指向假定的结合腔。同样在ETB中,Asp147和Asp154位于His150下方和上方一个螺旋圈,His150是与Tyr129对应的残基。ETA中的Asp126和ETB中的Asp147对应于许多GPCR的TM2中存在的高度保守的天冬氨酸,该天冬氨酸经常被证明对激动剂效力至关重要。将人ETA受体的Asp126突变为丙氨酸导致对ET - 1的亲和力不变,对ET - 3的亲和力增加160倍,对ETA选择性萘磺酰胺BMS - 182874的亲和力降低。ET - 1对磷脂酶C的激活被消除。此外,尽管结合亲和力增加,但ET - 3未能激活磷脂酶C,表明Asp126是信号转导所必需的。将Asp133突变为丙氨酸表明它仅对BMS - 182874的结合至关重要。在ETB受体中,将His150突变为丙氨酸或酪氨酸表明它在ETB亚型选择性配体结合中起次要作用;ETB的TM2中天冬氨酸的突变未改变配体结合。与Asp126 Ala ETA变体一样,ET - 1和ET - 3未能增加Asp147Ala ETB突变体中肌醇磷酸的细胞内水平。综上所述,这些数据支持以下假设:ETA受体TM2中Tyr129两侧的Asp126和Asp133在定义ETA亚型选择性配体结合中起作用,但ETB受体TM2中His150两侧的Asp147和Asp154不起作用。此外,这些数据表明ETA中的Asp126和ETB中的Asp147对于通过磷脂酶C的跨膜信号传导很重要。